KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
KAMADA LTD
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 11, 2026
$7.61−0.15 (-1.93%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 21.7
- Dividend yield
- –
Kamada statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Kamada | Industry median |
|---|---|---|
| Market Cap | $438.99M | $197.05M |
| Enterprise Value | $373.45M | $106.56M |
| PS Ratio | 2.43 | 3.93 |
| P/OCF Ratio | 17.22 | 13.78 |
Enterprise value
| Measure | Kamada | Industry median |
|---|---|---|
| EV / Sales | 2.07 | 2.69 |
| EV / EBITDA | 9.07 | 14.86 |
| EV / EBIT | 14.24 | 19.00 |
Income (trailing twelve months)
| Measure | Kamada | Industry median |
|---|---|---|
| Revenue | $180.46M | $57.94M |
| Gross Profit | $76.41M | $90.47M |
| Operating Income | $26.23M | -$21.44M |
| Pretax Income | $23.47M | -$14.45M |
| EBITDA | $41.15M | -$16.91M |
Margins
| Measure | Kamada | Industry median |
|---|---|---|
| Gross Margin | 42.3% | 52.3% |
| Operating Margin | 14.5% | -44.5% |
| Pretax Margin | 13.0% | -13.0% |
| EBITDA Margin | 22.8% | -31.3% |
Returns
| Measure | Kamada | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | 7.92% | -37.8% |
Growth
| Measure | Kamada | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 12.1% | 6.01% |
| Revenue Growth (3Y CAGR) | 11.7% | 2.25% |
| Revenue Growth (5Y CAGR) | 6.25% | 6.42% |
| EPS Growth (5Y CAGR) | -1.63% | 3.77% |
Balance sheet
| Measure | Kamada | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $75.47M | $62.42M |
| Total Debt | $9.92M | $120.13M |
| Net Cash (Debt) | $65.55M | $15.68M |
| Net Cash Per Share | $1.14 | $0.65 |
| Working Capital | $145.68M | $75.77M |
Financial position
| Measure | Kamada | Industry median |
|---|---|---|
| Current Ratio | 4.07 | 3.30 |
| Quick Ratio | 2.16 | 2.39 |
| Debt / EBITDA | 0.24 | 3.35 |
| Net Debt / EBITDA | -1.59 | 2.22 |
| Interest Coverage | 30.36 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Kamada | Industry median |
|---|---|---|
| Operating Cash Flow | $25.49M | -$12.35M |
Efficiency
| Measure | Kamada | Industry median |
|---|---|---|
| Asset Turnover | 0.48 | 0.38 |
| Inventory Turnover | 1.27 | 2.67 |
| Revenue Per Employee | $459.19K | $398.96K |
| Employee Count | 393 | 73 |
Shares
| Measure | Kamada | Industry median |
|---|---|---|
| Shares Outstanding | 57,686,100 | 59,128,900 |
| Float | 31,531,300 | 48,744,500 |
| Shares Held by Insiders | 45.3% | 11.8% |
Taxes
| Measure | Kamada | Industry median |
|---|---|---|
| Income Tax | $3.27M | $91.50K |
| Effective Tax Rate | 13.9% | 20.6% |
Scores
| Measure | Kamada | Industry median |
|---|---|---|
| Altman Z-Score | 3.51 | 0.10 |
Calculated by StockData from Kamada's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.